肌钙蛋白I测定在感染性休克监测中的应用价值研究  

Value Research in Troponin I Determined in the Application of Monitoring Infectious Shock

作　　者：高云翔 胡盛 

机构地区：[1]中山市大涌医院,广东中山528447

出　　处：《按摩与康复医学》2013年第6期12-13,共2页Chinese Manipulation and Rehabilitation Medicine

摘　　要：目的：探讨肌钙蛋白I在感染性休克患者中的变化情况，并分析其变化和疾病预后的关系。方法：对我院52例感染性休克患者进行回顾性分析，在进行急诊抢救后，测定肌钙蛋白I的含量，并根据其升高情况分为升高组和正常组，比较两组患者的最大血管活性药物需要量、急性生理和慢性健康状况评估Ⅱ（APAcHEⅡ）评分及死亡率。结果：升高组的最大血管活性药物需要量及死亡率均高于正常组（P〈0．05）；APACHEII评分虽稍高于正常组，但差异无统计学意义（P〉0．05）。结论：感染性休克患者肌钙蛋白I的水平与患者的预后密切相关，其升高的患者往往预后更差，可作为感染性休克预后监测的一项可靠指标，值得临床推广使用。Objective： To investigate the changes of troponin I applied in patients with infectious shock, and to analyze its changes and the prognosis relationships of the disease. Methods： A retrospective analysis was performed on 52 cases of infectious shock in our hospital, content of troponin I was determined after emergency rescue, according to the rising situation of which was divided into increased group and normal group, to compare the maximum amount of vasoactive drugs demanded, scores and mortality of acute physiology and chronic health evaluation II（APACHE II） between two groups. Results： The maximum amount of vasoactive drugs demanded and mortality of increased group were both higher than those of normal group （P〈0.05）; scores of APACHE II of increased group was slightly higher, but there was no statistically significance between two groups （P〉 0.05）. Conclusion： Troponin I levels of patients with infectious shock is closely related with their prognosis, increasing troponin I usually leads to worse prognosis, which can be used as a reliable prognosis indicator of infectious shock, being worthy of clinical popularization and application.

关 键 词：感染性休克 肌钙蛋白I 预后 

分 类 号：R631.4[医药卫生—外科学]